TransCode Therapeutics Inc (NASDAQ: RNAZ) closed the day trading at $0.64 down -8.60% from the previous closing price of $0.70. In other words, the price has decreased by -$0.0521 from its previous closing price. On the day, 1322766 shares were traded. RNAZ stock price reached its highest trading level at $0.7190 during the session, while it also had its lowest trading level at $0.6250.
Ratios:
For a better understanding of RNAZ, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.67 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.04.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 28 ’23 when Dudley Robert Michael bought 98,000 shares for $0.51 per share. The transaction valued at 49,980 led to the insider holds 180,262 shares of the business.
Fitzgerald Thomas A bought 49,350 shares of RNAZ for $25,168 on Sep 28 ’23. The Chief Financial Officer now owns 56,318 shares after completing the transaction at $0.51 per share. On Jun 21 ’23, another insider, Dudley Robert Michael, who serves as the Chief Executive Officer of the company, bought 12,000 shares for $2.65 each. As a result, the insider paid 31,818 and bolstered with 82,262 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNAZ now has a Market Capitalization of 738.30k and an Enterprise Value of -6.12M.
Stock Price History:
Over the past 52 weeks, RNAZ has reached a high of $392.00, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 1.9384, while the 200-Day Moving Average is calculated to be 42.4572.
Shares Statistics:
Over the past 3-months, RNAZ traded about 610.14K shares per day on average, while over the past 10 days, RNAZ traded about 399.58k shares per day. Insiders hold about 0.53% of the company’s shares, while institutions hold 0.28% stake in the company. Shares short for RNAZ as of Feb 15, 2024 were 220.91k with a Short Ratio of 0.36, compared to 9.85k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 20.91% and a Short% of Float of 21.03%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$10.8 for the current quarter, with a high estimate of -$10.8 and a low estimate of -$10.8, while EPS last year was -$264. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$222.8 and -$222.8 for the fiscal current year, implying an average EPS of -$222.8. EPS for the following year is -$25.2, with 1 analysts recommending between -$25.2 and -$25.2.
